Genomics has guided personalized cancer treatments for the past two decades. Now, AI biomarkers are expanding the field, helping radiologists and radiation oncologists stratify risk and potentially plan more precise treatments. Unlike traditional biomarkers, “AI analyzes images of a patient’s biopsy

Healthcare has reached a critical juncture. The World Economic Forum estimates that global medical costs will see double digit increases for the third consecutive year since 2023, with estimates suggesting an average rise of 10.4 percent worldwide in 20251 driven by factors including overwhelmed

Dec. 1, 2025 — A study of data from seven outpatient facilities in the New York region found that 20-24% of all the breast cancers diagnosed during an 11-year period were found in women age 18 to 49, according to research being presented at RSNA 2025. "This research shows that a significant

Nov. 30, 2025 — At RSNA 2025, Konica Minolta Healthcare Americas announced the new KDR FMT and KDR FMT+ digital radiography (DR) systems. The KDR FMT and KDR FMT+ represent the next evolution in floor-mounted DR systems from Konica Minolta, designed to deliver high image quality, reliability and

Nov. 26, 2025 — GE HealthCare has announced it received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstruction technology. Powered by deep learning, Pristina Recon DL sets a new standard in image definition and sharpness. Breast cancer remains one of the